News Releases

This section features all recent CSL Behring news releases. Click the tabs to select releases in your area of interest. Click Resources to find additional background material on CSL Behring.

All Releases
Bleeding Disorders
Hereditary Angioedema (HAE)
Fluid Management


07 September 2017 CSL Behring Presents New Alpha 1 Antitrypsin Deficiency Treatment Data at Global ERS Congress

CSL Behring presents data and hosts symposium on real life experiences with Alpha-1.

> Read More
05 April 2017 CSL Behring Presents Data on RAPID Trial Extension and Supports Alpha-1 International Research and Patient Conference

CSL Behring continues legacy of support for Alpha-1 Community with Global Research Conference and Patient Congress Sponsorship.

> Read More
02 December 2016 The Lancet Respiratory Medicine Publishes RAPID Extension Study Data Confirming Disease-modifying Effect of Respreeza® [Alpha1-Proteinase Inhibitor (Human)] in Patients with Alpha-1 Antitrypsin Deficiency (AATD)

CSL Behring’s RAPID Extension Study data confirms disease-modifying effect of Respreeza® in patients with AATD.

> Read More
Page 1 of 1

LinkedIn Twitter Facebook Google+